Anavex Life Sciences Corp (AVXL)

[XenaLives]

Chart study -

AMRN is a 15 day chart, just to provide better visual clarity. I wanted to use 9 days for all but the 15 was so much easier to read.



330 million shares 37% insty as of 6/30/18

 
 09/25/18	12.21	14.64	11.96	13.00	106,046,500 
 09/24/18	10.44	12.47	9.51	12.40	160,260,500 
 09/21/18	3.00	3.02	2.884	2.99	  4,215,567 
 09/20/18	2.85	2.97	2.775	2.93      2,947,723

ARWR 9 day chart - no gap up but once it broke out of that basing area it went up rapidly with a roughly 25% pullback in the last quarter of 2018. Note the hard crash at the end of 2016 and recovery didn't begin until Fall of 2017. Very similar to AVXL in 2018.



AVXL - basing area is from roughly $2.50 to $6.50. With news of a successful trial we will surely break $6.50. With approval $14 is the gap up target. A very interesting positive divergence between OBV and price here. Shorts are going to get hurt, IMO.